Revisão Revisado por pares

Pharmacologic Treatment of Perinatal Depression

2018; Elsevier BV; Volume: 45; Issue: 3 Linguagem: Inglês

10.1016/j.ogc.2018.04.007

ISSN

1558-0474

Autores

Mary Kimmel, Elizabeth Cox, Crystal Edler Schiller, Edith Gettes, Samantha Meltzer‐Brody,

Tópico(s)

Child Nutrition and Feeding Issues

Resumo

This review provides information about medications used to treat perinatal depression, including guidance around when to use certain medications and when to consult a mental health provider. For each group of medications, including selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, mirtazapine, bupropion, lithium, atypical antipsychotics, and lamotrigine, the risks and benefits of treatment during pregnancy and lactation are reviewed, and unique qualities of each medication. A treatment algorithm is included and a description of the Food and Drug Administration's approach to providing information about medications. The article also discusses hormone therapies and future directions for new pharmacologic treatments.

Referência(s)